{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:43:38Z","timestamp":1763988218303,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Comision Nacional de Investigacion Cientifica y Tecnologica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008736","name":"FONDEF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jgar.2021.08.012","type":"journal-article","created":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T09:43:22Z","timestamp":1630835002000},"page":"160-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical, electrocardiographic and echocardiographic evolution of chronic Chagas disease treated with nifurtimox on prolonged follow\u2010up in Chile: observational study"],"prefix":"10.1016","volume":"27","author":[{"given":"Werner","family":"Apt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Llancaqueo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-0413","authenticated-orcid":false,"given":"In\u00e9s","family":"Zulantay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-4439","authenticated-orcid":false,"given":"Mauricio","family":"Canals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Arribada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2021.08.012_bib0001","first-page":"33","article-title":"Chagas disease in Latin America and epidemiological update based on 2010 estimates","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jgar.2021.08.012_bib0002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: a Latin American health problem becoming a world health problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2021.08.012_bib0003","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/S0140-6736(18)30776-1","article-title":"Chagas disease cardiomyopathy treatment remains a challenge","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2021.08.012_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5245021","article-title":"Emerging and neglected infectious diseases: insights, advances, and challenges","volume":"2017","author":"Nii-Trebi","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jgar.2021.08.012_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)61422-7","article-title":"Socioeconomic aspects of neglected tropical diseases","volume":"375","author":"Conteh","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2021.08.012_bib0006","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02762007000900018","article-title":"Chagas disease: what is known and what is needed\u2014a background article","volume":"1","author":"Coura","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jgar.2021.08.012_bib0007","series-title":"American trypanosomiasis: Chagas disease. One hundred years of research","first-page":"653","article-title":"Clinical phases and forms of Chagas disease","author":"Rassi","year":"2017"},{"key":"10.1016\/j.jgar.2021.08.012_bib0008","first-page":"358","article-title":"Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy?","volume":"91","author":"Silva","year":"2008","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jgar.2021.08.012_bib0009","doi-asserted-by":"crossref","first-page":"e35116","DOI":"10.1371\/journal.pone.0035116","article-title":"Stroke correlates in chagasic and non-chagasic cardiomyopathies","volume":"7","author":"da Matta","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2021.08.012_bib0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/hrt.2008.159624","article-title":"Challenges and opportunities for primary, secondary and tertiary prevention of Chagas' disease","volume":"95","author":"Rassi","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jgar.2021.08.012_bib0011","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1586\/14779072.2015.1103648","article-title":"Developments in the management of Chagas cardiomyopathy","volume":"13","author":"Tanowitz","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jgar.2021.08.012_bib0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4269\/ajtmh.2004.70.210","article-title":"Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic Chagas heart disease","volume":"70","author":"Schijman","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.08.012_bib0013","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ejhf.220","article-title":"Chagas Study Group of the NHLBI Retrovirus Epidemiology Donor Study II, International Component. Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity","volume":"17","author":"Sabino","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jgar.2021.08.012_bib0014","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ajpath.2014.12.023","article-title":"Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead","volume":"185","author":"Bonney","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jgar.2021.08.012_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actatropica.2017.09.017","article-title":"Trypanosoma cruzi genetic diversity: something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","volume":"184","author":"Zingales","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2021.08.012_bib0016","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.actatropica.2018.05.004","article-title":"Discrete typing units of Trypanosoma cruzi detected by real-time PCR in Chilean patients with chronic Chagas cardiomyopathy","volume":"185","author":"Mu\u00f1oz-San Mart\u00edn","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2021.08.012_bib0017","first-page":"97","article-title":"Tratamiento de la enfermedad de Chagas cr\u00f3nica en Chile. Efectos adversos de nifurtimox [Treatment of chronic Chagas disease in Chile. Side effects of nifurtimox]","volume":"71","author":"Valencia","year":"2012","journal-title":"Rev Ibero-Latin Parasitol"},{"key":"10.1016\/j.jgar.2021.08.012_bib0018","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/cid\/ciw477","article-title":"Safety profile of nifurtimox for treatment of Chagas disease in the United States","volume":"63","author":"Forsyth","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.08.012_bib0019","series-title":"American trypanosomiasis: Chagas disease. One hundred years of research","first-page":"751","article-title":"Treatment of Chagas disease","author":"Apt","year":"2017"},{"journal-title":"World Chagas Disease Day: bringing a forgotten disease to the fore of global attention","first-page":"2020","year":"2020","key":"10.1016\/j.jgar.2021.08.012_bib0020"},{"first-page":"VIII","year":"2018","series-title":"Gu\u00eda para el diagn\u00f3stico y tratamiento de la enfermedad de Chagas [Guide for the diagnosis and treatment of Chagas disease]","key":"10.1016\/j.jgar.2021.08.012_bib0021"},{"key":"10.1016\/j.jgar.2021.08.012_bib0022","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.actatropica.2016.06.025","article-title":"Chronic Chagas cardiopathy in Chile. Importance of Trypanosoma cruzi burden and clinical evaluation","volume":"162","author":"Apt","year":"2016","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2021.08.012_bib0023","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/trstmh\/trs013","article-title":"Congenital infection by Trypanosoma cruzi in an endemic area of Chile: a multidisciplinary study","volume":"107","author":"Apt","year":"2013","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.08.012_bib0024","first-page":"47","article-title":"Electrocardiographic classification and abbreviated lead system for population-based studies of Chagas' disease","volume":"16","author":"Maguire","year":"1982","journal-title":"Bull Pan Am Health Organ"},{"year":"2017","series-title":"Manual de Procedimientos para la Atenci\u00f3n de Pacientes con Enfermedad de Chagas [Manual of procedures for the care of patients with Chagas disease]","key":"10.1016\/j.jgar.2021.08.012_bib0025"},{"key":"10.1016\/j.jgar.2021.08.012_bib0026","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pst.1573","article-title":"Tests of marginal homogeneity and special cases","volume":"12","author":"Dunnigan","year":"2013","journal-title":"Pharm Stat"},{"key":"10.1016\/j.jgar.2021.08.012_bib0027","first-page":"245","article-title":"A four-year followup survey of chagasic cardiopathy in Chile","volume":"20","author":"Arribada","year":"1986","journal-title":"PHAO Bulletin"},{"key":"10.1016\/j.jgar.2021.08.012_bib0028","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12968-015-0200-7","article-title":"Myocardial tissue characterization in Chagas heart disease by cardiovascular magnetic resonance","volume":"17","author":"Torreao","year":"2015","journal-title":"J Carciovasc Magn Reson"},{"key":"10.1016\/j.jgar.2021.08.012_bib0029","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.crad.2016.02.015","article-title":"Value of cardiac MRI for evaluation of chronic Chagas disease cardiomyopathy","volume":"71","author":"Lee-Felker","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jgar.2021.08.012_bib0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12968-016-0307-5","article-title":"Chagas\u2019 heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance","volume":"18","author":"Assuncao","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jgar.2021.08.012_bib0031","doi-asserted-by":"crossref","first-page":"e2078","DOI":"10.1371\/journal.pntd.0002078","article-title":"Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors","volume":"7","author":"Ribeiro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2021.08.012_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157597","article-title":"Chagas cardiomyopathy: usefulness of EKG and echocardiogram in a non-endemic country","volume":"11","author":"S\u00e1nchez-Montalv\u00e1","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2021.08.012_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006567","article-title":"Electrocardiographic abnormalities in Chagas disease in the general population: a systematic review and meta-analysis","volume":"12","author":"Rojas","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2021.08.012_bib0034","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/jac\/dkt135","article-title":"Treatment of Chagas' disease with itraconazole: electrocardiographic and parasitological conditions after 20 years of follow-up","volume":"68","author":"Apt","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.08.012_bib0035","doi-asserted-by":"crossref","first-page":"ofz012","DOI":"10.1093\/ofid\/ofz012","article-title":"Progression of baseline electrocardiogram abnormalities in Chagas patients undergoing antitrypanosomal treatment","volume":"6","author":"Soverow","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2021.08.012_bib0036","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"BENEFIT Investigators. Randomized trial of benznidazole for chronic Chagas' cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2021.08.012_bib0037","series-title":"Cardiopat\u00edas parasitarias [Parasitic heart disease]","first-page":"39","author":"Arribada","year":"1980"},{"key":"10.1016\/j.jgar.2021.08.012_bib0038","first-page":"e169","volume":"138","author":"Nunes","year":"2018","journal-title":"American Heart Association. Circulation"},{"key":"10.1016\/j.jgar.2021.08.012_bib0039","series-title":"Chagas disease a clinical approach, Birkh\u00e4user advances in infectious diseases","first-page":"199","article-title":"Clinical care for individuals with chronic Trypanosoma cruzi infection. Decision-making in the midst of uncertainty","author":"Villar","year":"2019"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:57:16Z","timestamp":1761991036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716521002046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S2213716521002046"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2021.08.012","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, electrocardiographic and echocardiographic evolution of chronic Chagas disease treated with nifurtimox on prolonged follow\u2010up in Chile: observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2021.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}